CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-21 | Bonfiglio Patrice Eadon Director | Grant or award · Stock Option (Right to Buy) | +284,598 | 284,598 | ||
| 2023-07-21 | Bonfiglio Patrice Eadon Director | Grant or award · Stock Option (Right to Buy) | +167,411 | 167,411 | ||
| 2023-07-21 | Bonfiglio Patrice Eadon Director | Grant or award · Restricted Stock Units | +94,866 | 94,866 | ||
| 2023-07-21 | Bonfiglio Patrice Eadon Director | Grant or award · Restricted Stock Units | +55,804 | 55,804 | ||
| 2023-07-21 | Sullivan Diane E. Director | Grant or award · Stock Option (Right to Buy) | +284,598 | 284,598 | ||
| 2023-07-21 | Sullivan Diane E. Director | Grant or award · Stock Option (Right to Buy) | +167,411 | 167,411 | ||
| 2023-07-21 | Sullivan Diane E. Director | Grant or award · Restricted Stock Units | +94,866 | 94,866 | ||
| 2023-07-21 | Sullivan Diane E. Director | Grant or award · Restricted Stock Units | +55,804 | 55,804 | ||
| 2023-07-19 | Berg Aaron EVP, President US | Grant or award · Stock Option (right to buy) | +404,400 | $1.08 | $437K | 404,400 |
| 2023-07-19 | Reilly Thomas Charles SVP and CFO | Grant or award · Stock Option (right to buy) | +404,400 | $1.08 | $437K | 404,400 |
| 2023-07-19 | Ketchum Steven B Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +404,400 | $1.08 | $437K | 404,400 |
| 2023-07-01 | Reilly Thomas Charles SVP and CFO | Option exercise | +16,667 | 33,584 | ||
| 2023-07-01 | Reilly Thomas Charles SVP and CFO | Shares withheld for taxes | −8,209 | $1.19 | $10K | 25,375 |
| 2023-07-01 | Reilly Thomas Charles SVP and CFO | Option exercise · Restricted Stock Units | −16,667 | 33,333 | ||
| 2023-06-20 | Reilly Thomas Charles SVP and CFO | Option exercise | +33,334 | 33,334 | ||
| 2023-06-20 | Reilly Thomas Charles SVP and CFO | Shares withheld for taxes | −16,417 | $1.19 | $20K | 16,917 |
| 2023-06-20 | Reilly Thomas Charles SVP and CFO | Option exercise · Restricted Stock Units | −33,334 | 66,666 | ||
| 2023-02-28 | Berg Aaron EVP, President US | Option exercise | +16,333 | 518,478 | ||
| 2023-02-28 | Berg Aaron EVP, President US | Shares withheld for taxes | −7,718 | $2.03 | $16K | 510,760 |
| 2023-02-28 | Berg Aaron EVP, President US | Option exercise · Restricted Stock Units | −16,333 | 0 |
Page 15 of 67 · 1,339 trades